Abstract
The articles reported in this issue of theArchivesraise several questions about warts that dermatologists and other physicians must deal with daily. How are human papillomaviruses (HPV) transmitted? How are warts clinically detected, when will HPV typing be available, and when should we use it? What is the significance of infection with HPV types associated with cancer? How do warts resolve and what is the role of the immune system? Although definitive answers cannot be provided, I will attempt a selective interpretation of current data (for a more complete literature review see reference 1). <h3>EPIDEMIOLOGY OF HPV</h3> Rudlinger et al<sup>2</sup>describe a periungual wart with dysplastic pathology in a patient with chronic genital bowenoid papulosis. The identification of HPV-35, an uncommon HPV type usually limited to the genital region, in both lesions suggested spread from the vulvar disease. The case report of Ostrow et al<sup>3</sup>provides another
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
